Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.01 CAD -33.33% Market Closed
Market Cap: 636.6k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Income Statement

Earnings Waterfall
Replicel Life Sciences Inc

Revenue
353.7k CAD
Operating Expenses
-1.7m CAD
Operating Income
-1.4m CAD
Other Expenses
1.3m CAD
Net Income
-69.3k CAD

Income Statement
Replicel Life Sciences Inc

Rotate your device to view
Income Statement
Currency: CAD
Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Revenue
Revenue
4
N/A
0
N/A
4
N/A
4
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
+52%
0
+34%
0
+26%
0
+14%
0
-21%
0
+41%
0
+6%
0
-15%
0
+25%
0
-20%
0
N/A
0
0%
0
0%
0
N/A
0
N/A
0
+0%
0
0%
0
N/A
0
N/A
Operating Income
Operating Expenses
(3)
0
(4)
(5)
(5)
0
(5)
(5)
(5)
(5)
(5)
(4)
(4)
(4)
(5)
(7)
(7)
(6)
(5)
(3)
(2)
(3)
(3)
(4)
(4)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
Selling, General & Administrative
(2)
0
(2)
(3)
(3)
0
(3)
(3)
(3)
(3)
(3)
(3)
(2)
(3)
(4)
(4)
(4)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
Research & Development
(1)
0
(2)
(2)
(2)
0
(2)
(2)
(2)
0
(2)
(2)
(1)
(1)
(1)
(2)
(3)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(1)
0
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
(2)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
1
N/A
0
N/A
0
N/A
(0)
N/A
(5)
-976%
0
N/A
(5)
N/A
(5)
N/A
(5)
+2%
(5)
+2%
(5)
+2%
(4)
+12%
(4)
+12%
(4)
-12%
(5)
-14%
(7)
-35%
(7)
-9%
(6)
+16%
(5)
+20%
(3)
+40%
(2)
+15%
(3)
-12%
(3)
-16%
(4)
-11%
(3)
+6%
(3)
+12%
(2)
+18%
(2)
+15%
(2)
+2%
(1)
+32%
(2)
-35%
(2)
-13%
(2)
-1%
(2)
-10%
(2)
+6%
(2)
+15%
(1)
+20%
(1)
+6%
(2)
-8%
(1)
+18%
(1)
-11%
Pre-Tax Income
Interest Income Expense
(0)
0
(0)
(0)
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
0
0
0
(0)
(0)
(0)
(0)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(2)
(2)
1
1
1
2
Pre-Tax Income
1
N/A
0
N/A
(0)
N/A
(1)
-1 933%
(5)
-697%
0
N/A
(5)
N/A
(5)
+1%
(5)
+1%
(5)
+1%
(5)
+3%
(4)
+12%
(4)
+12%
(4)
-12%
(5)
-15%
(7)
-35%
(7)
-8%
(6)
+16%
(5)
+20%
(3)
+39%
(2)
+14%
(3)
-12%
(3)
-12%
(3)
-11%
(3)
+6%
(3)
+8%
(3)
+17%
(2)
+8%
(2)
-1%
(2)
+32%
(3)
-85%
(3)
-11%
(3)
-7%
(4)
-17%
(4)
+14%
(4)
-2%
(4)
-8%
(1)
+81%
(1)
-24%
(0)
+60%
(0)
+81%
Net Income
Tax Provision
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
0
0
(0)
(1)
(5)
0
(5)
(5)
(5)
(5)
(5)
(4)
(4)
(4)
(5)
(7)
(7)
(6)
(5)
(3)
(2)
(3)
(3)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(3)
(3)
(3)
(4)
(4)
(4)
(4)
(1)
(1)
(0)
(0)
Net Income (Common)
0
N/A
0
N/A
(0)
N/A
(1)
-129%
(5)
-372%
0
N/A
(5)
N/A
(5)
+1%
(5)
+1%
(5)
+1%
(5)
+3%
(4)
+12%
(4)
+12%
(4)
-12%
(5)
-15%
(7)
-35%
(7)
-8%
(6)
+16%
(5)
+20%
(3)
+39%
(2)
+14%
(3)
-12%
(3)
-12%
(3)
-11%
(3)
+6%
(3)
+8%
(3)
+17%
(2)
+8%
(2)
-1%
(2)
+32%
(3)
-70%
(3)
-12%
(3)
-8%
(4)
-26%
(4)
+14%
(4)
-2%
(4)
-8%
(1)
+81%
(1)
-24%
(0)
+60%
(0)
+81%
EPS (Diluted)
0.06
N/A
0
N/A
-0.08
N/A
-0.2
-150%
-0.91
-355%
0
N/A
-0.99
N/A
-0.96
+3%
-0.85
+11%
-0.89
-5%
-0.77
+13%
-0.65
+16%
-0.56
+14%
-0.54
+4%
-0.29
+46%
-0.35
-21%
-0.38
-9%
-0.32
+16%
-0.28
+13%
-0.15
+46%
-0.13
+13%
-0.12
+8%
-0.14
-17%
-0.14
N/A
-0.12
+14%
-0.12
N/A
-0.08
+33%
-0.07
+13%
-0.07
N/A
-0.06
+14%
-0.1
-67%
-0.11
-10%
-0.11
N/A
-0.13
-18%
-0.11
+15%
-0.11
N/A
-0.11
N/A
-0.02
+82%
-0.03
-50%
-0.01
+67%
0.01
N/A

See Also

Discover More